Monday, 13 July 2026 · Europe
EUR/USD 1.142 EUR/GBP 0.8533 EUR/CHF 0.9253 EUR/PLN 4.324 All rates →
Sign in · Join
EUROPES The European Report
LATEST
Longevity

Qihan scores FDA ‘triple crown’ for cell therapy

Qihan scores FDA ‘triple crown’ for cell therapy
Longevity.Technology

Chinese biotech’s universal CAR-T therapy secures FDA’s three top expedited designations, potentially accelerating its path to patients. Qihan Biotech has reached a landmark moment in its journey to bring next-generation cell therapies to patients. The Hangzhou-based company has announced that its lead candidate, QT-019B, has received both Regenerative Medicine Advanced Therapy (RMAT) designation and Breakthrough […] The post Qihan scores FDA ‘triple crown’ for cell therapy appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.

Read full coverage at Longevity.Technology →

More from Longevity